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Overview of short bowel syndrome and intestinal transplantation
DEBORA DURO, M.D., M.S.*, D ANIEL  KAMIN, M.D.*
SUMMARY
Short bowel syndrome is at once a surgical, medical, and a disorder, with potential for life-threatening complications as well as
eventual independence from artificial nutrition.  Navigating through the diagnostic and therapeutic decisions is ideally accomplished
by a multidisciplinary team comprised of nutrition, pharmacy, social work, medicine, and surgery. Early identification of patients
at risk for long-term PN-dependency is the first step towards avoiding severe complications. Close monitoring of nutritional status,
steady and early introduction of enteral nutrition, and aggressive prevention, diagnosis and treatment of infections such as line
sepsis, and bacterial overgrowth can significantly improve prognosis.  Intestinal transplantation is an emerging treatment that may
be considered when intestinal failure is irreversible and children are suffering from serious complications related to TPN
administration.  
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Actualización sobre síndrome de intestino corto y transplante intestinal
RESUMEN
El síndrome de intestino corto es una entidad médico-quirúrgico, con potencial riesgo para poner en peligro la vida de los niños,
y que en su manejo incluye nutrición artificial. El estudio diagnóstico y terapéutico se logra idealmente con un equipo
multidisciplinario compuesto de nutricionista, químico, trabajadora social, médico y cirujano. Uno de los primeros pasos, es la
identificación anticipada de pacientes a riesgo de presentar complicaciones severas por el uso prolongado de nutrición parenteral.
Su pronóstico se mejora con la estrecha supervisión del estado nutricional, por la introducción temprana de la nutrición enteral y
la prevención a tiempo en el diagnóstico y tratamiento de infecciones bien de la línea arterial, o por sobrecrecimiento bacteriano.
El transplante intestinal emerge como parte del tratamiento que puede ser considerado cuando la falla intestinal es irreversible y
en los niños que presentan complicaciones serias relacionadas con la administración de nutrición parenteral.
Palabras clave: Síndrome de intestino corto; Transplante intestinal; Niños.
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The small bowel is completely formed by 20 weeks of
gestation. Most of its growth occurs in the 3rd trimester
gestation and increases to approximately 250 cm with a
diameter of 1.5 cm after 35 weeks of gestation1. An adult
small intestine is 600 to 800 cm in length and 4 cm in
diameter. The mucosal surface area increases with age;
an average infant’s intestine is about 950 cm2 compared
with an adult intestine of 7500 cm2. Normal intestinal
growth and development are uniquely important for
understanding the pathophysiology of pediatric Short Bowel
Syndrome (SBS). For instance, the age of the child at the
time of intestinal resection may crucially impact the potential
for remaining bowel to adapt2. The classic prognostic
factors in SBS include the length and site of resection,
underlying intestinal disease, status of other digestive
organs, and adaptive capability of remaining intestine3.
The nutritional management begins in the early
postoperative period. The goals should be towards improving
overall quality of life by maintaining normal nutritional
status and preventing complications associated with SBS.
This article discuss briefly an overview in SBS presenting
the definition, etiology, pathophysiology, complications
and the overall management including some considerations
for surgical approach and intestinal transplantation.
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DEFINITION OF SHORT BOWEL SYNDROME
AND ITS ETIOLOGY
There is no specific anatomical definition. By convention,
animal studies often use 80% resection or greater to define
SBS. In the pediatric population the definition most used
and accepted is based on function. SBS is a malabsorptive
state occurring as a result of loss of a significant portion of
the intestine for acquired or congenital diseases leading to
dependence on parenteral nutrition for 1-3 months.
The incidence and prevalence of SBS are estimated to
be 3 per million and 4 per million, respectively4. These
numbers reflect almost exclusively those individuals
requiring parenteral nutrition and are based on numbers in
studies done in Europe. Short Bowel Syndrome is the
predominant cause of intestinal failure in children and is
related to congenital causes such as atresias, gastroschisis
or acquired conditions including volvulus, and necrotizing
enterocolitis5,6 (Table 1).
PATHOPHYSIOLOGY
The pathophysiology of SBS depends on the extent of
the resection and the location of residual small bowel or
colon. There is no anatomical distinction that demarcates
jejunum from ileum. The proximal 2/5 of small bowel is
usually accepted as jejunum and the distal 3/5 as ileum.
Most carbohydrates, fats, proteins, vitamins, minerals and
trace elements are absorbed within the first 2/3 of the
small bowel. Most iron is absorbed in the duodenum and
folate in the proximal jejunum. Vitamin B12 and bile salts
are only absorbed in the distal ileum. Water and electrolytes
are absorbed through the entire small bowel and colon.
The ileum is the most common intestinal segment to be
resected. Intestinal transit may be rapid due to a loss of the
ileal and colonic 7 break making diarrhea a common
complication. With loss of terminal ileum, choleretic diarrhea
may occur due to bile salt malabsorption. However, even
with extensive ileal resections, calorie and fluid absorption
may be adequate since these functions occur largely in the
jejunum.
Although uncommon, jejunal resections carry the best
prognosis. The ileal brake maintains normal intestinal
transit so that diarrhea is less common.
The loss of the ileal cecal valve (ICV) may have
consequences. The ICV functions as a major barrier to
reflux of colonic material from the colon into the small
intestine, and assists in regulating the exit of fluid and
nutrients from the ileum into the colon. Very common
complications can occur with loss of ICV such as bacterial
overgrowth and difficulty of weaning from parenteral
nutrition8.
COMPLICATIONS AND OVERALL
MANAGEMENT
The most important SBS complications relate to the
need to administer central venous parenteral nutrition9.
Liver disease may develop, and is characterized by steatosis,
cholestasis and even cirrhosis. Central venous catheter
complications may occur, such as catheter breakage,
central venous thrombosis, and catheter-related bacterial
or fungal sepsis. Other common complications depend on
the length, nature, and surgical anatomy of the remaining
small bowel. Malabosrptive diarrhea, fluid and electrolyte
abnormalities, micronutrient deficiencies, gastric hyper-
secretion, anastomotic ulcers and bacterial overgrowth8
all can occur in children with SBS. These children require
Table 1
Etiology of short bowel syndrome
 Prenatal       Neonatal  Postnatal
Atresia (unique or multiple) Midgut volvulus (midgut or segmental) Midgut volvulus (malrotation, bands, or
tumor)
Apple peel syndrome Necrotizing enterocolitis Complicated intussusception
Midgut volvulus (malrotation) Arterial thrombosis Arterial thrombosis
Segmental volvulus (with omphalomesenteric Venous thrombosis Inflammatory bowel disease
duct or intra-abdominal bands)
Abdominal wall defects Postrauma resection
Gastroschisis > Omphalocele
Extensive Hirschsprung´s disease Extensive angioma
From Goulet O et al.5
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careful ongoing monitoring and treatment even in a light of
normal somatic growth and or limited resected segment of
bowel10.
Medical management ought to focus on nutrition, which
includes monitoring the provision of calories, micronutrients,
fluid, and electrolytes. Usually patients require parenteral
nutrition for a period of time. Most can be successfully
transitioned to full enteral nutrition11. The gold standard for
success is growth once completely off parenteral nutrition,
as well as the maintenance of normal vitamin nutriture and
liver function12.
Many times children with SBS require medications to
help overcome some of the complications associated with
SBS. Gastric acid hypersecretion can impair absorption of
nutrients and precipitate diarrhea; acid blockade with
proton pump inhibitors can be useful in this regard. Multiple
mechanisms motivate the use of loperamide, fiber,
octreotide, and cholestyramine for the control of voluminous
and watery stool or ostomy output. In patients with
prolonged exposure to parenteral nutrition, ursodeoxycholic
acid may hasten improvement in the cholestasis. Bacterial
overgrowth often necessitates the use of rotating courses
of enteral antibiotics. The supplementation of vitamins and
minerals, especially the fat soluble vitamins A, D, E and K,
is fundamental for the preservation of nutritional status in
children with SBS.
SURGICAL CONSIDERATIONS
Often surgery is the most appropriate therapy to
achieve full enteral nutrition. The most common is the
placement of feeding device directly into the gastrointestinal
(GI) tract. Typically this is a gastrostomy tube, but gastro-
jejunal or jejunostomy tubes also play a role for patients
with abnormal gastric and/or duodenal motility. The primary
purpose of such tubes is the continuous administration of
enteral nutrition. Continuous, steady administration of
enteral nutrition is more likely to be tolerated than oral
bolus feeding in children with SBS13.
Often children with SBS have small intestinal ostomies
even while colon may also be present but ‘not in continuity’,
i.e. chyme does not pass through a given segment of
intestine. As soon as it is surgically and medically appro-
priate, such segments should be utilized by ‘taking down’
ostomies and allowing intestinal contents to have maximum
contact time with small and large intestine. This gives the
GI tract the best chance to absorb nutrients, fluid, and
electrolytes.
Intestinal lengthening procedures take advantage of
the bowel dilation that often occurs in the foreshortened
remaining small intestine. LILT, or longitudinal intestinal
lengthening and tailoring, was described in 198014, and has
now been employed widely. This procedure divides
symmetrically dilated segments of small bowel in half
longitudinally, preserving blood flow by separating the
leaves of mesentery with either limb. The lumen is re-
created by forming two narrower channels, which are then
re-approximated one to the other in series, effectively
doubling the length of the intestinal lumen. Results have
been favorable 15.
The serial transverse enteroplasty (STEP) procedure
was more recently described16, and has now been performed
widely and was used recently to treated some specific
complications17. It has the advantage of being simpler,
requires no enterotomies, preserves natural intestinal
vasculature, and can be applied to asymmetrically dilated
segments of bowel. The procedure entails applying a
surgical stapler at right angles to the bowel successively,
alternating sides, so as to create a ‘zig-zag’ longer and
narrower channel. A recently created STEP Registry18
reported that enteral tolerance increased by 116% in 38
patients, and nearly half had been weaned off TPN after
a median follow-up of 12.6 months.
INTESTINAL TRANSPLANTATION
Intestinal transplantation is indicated when intestinal
failure is considered permanent, and the administration of
TPN is resulting in life-threatening complications. This has
been operationally defined as:
1. Significant liver injury with abnormal hepatic enzymes.
2. Multiple central line infections.
3. Thrombosis of at least two central veins.
4. Frequent severe episodes of dehydration19.
The most common intestinal transplants can be catego-
rized as follows:
1. Isolated intestine- transplantation of the small intestine
with or without the large intestine;
2. En bloc liver intestine- the duodenum, pancreas, liver,
and small intestine are included ‘in one piece’ so as not
to disrupt the biliary tract;
3. Multivisceral-  removal and replacement of the native
foregut and midgut. Graft choice usually depends on
the size of the recipient, the presence or absence of
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significant liver disease, and if there is significant
pathology extending beyond the small intestine (e.g.
pseudoobstruction affecting stomach and small bowel).
Since its entry into the clinical use in the 1980s20
outcomes after intestinal transplantation have dramatically
improved. The average one year survival after intestinal
transplant is 80%21, and at some centers this value exceeds
90%. Chronic parenteral nutrition is costly and burden-
some22, while average 5 year survival may be as low as
60% 21. Transplantation still carries significant morbidity
and mortality, patients remain on life long immune
suppression, and 5 year survival rates (on average 50%)
are sub-optimal19. Nevertheless, current indications have
been questioned19,21,22, in anticipation of continued
improvements in patient and graft survival. Thus, indications
may evolve over the coming years to include children with
permanent intestinal failure but without necessarily
suffering from severe, life-threatening complications.
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